Task: Answer the multiple-choice question.
Query: Which drug exhibits a 16.201\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] N#Cc1c(-c2ccc(F)cc2)cc(-c2cccs2)nc1SCC(=O)O
[b] Cc1[nH]nc(N2CCCCC2)c1[N+](=O)[O-]
[c] Cc1cc(=O)[nH]c(NCc2ccc(Cl)cc2)n1
Answer: a. N#Cc1c(-c2ccc(F)cc2)cc(-c2cccs2)nc1SCC(=O)O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#Cc1c(-c2ccc(F)cc2)cc(-c2cccs2)nc1SCC(=O)O
N#Cc1c(-c2ccc(F)cc2)cc(-c2cccs2)nc1SCC(=O)O
2-[3-cyano-4-(4-fluorophenyl)-6-thiophen-2-ylpyridin-2-yl]sulfanylacetic acid